Exact Sciences makes Cologuard, a colorectal cancer diagnostic test that can be used at home to screen for DNA biomarkers in stool samples. It was approved by the U.S. Food and Drug Administration in 2014, and during the first three months of this year, more than 2 million patients had used it.

Exact Sciences entered into a contract with WEDC in 2014 that could net it $9 million in tax credits. To date, it has qualified for $4.3 million. In 2017, it was awarded $1 million. Of that , about 6%, or $61,000, was for the 261 jobs created outside Wisconsin. It had also created 795 jobs in the state.

The contract required Exact Sciences to create 754 jobs in Wisconsin by 2020 to get the full amount, company spokeswoman Connelly said. The company has already surpassed that number and has 1,607 qualifying employees in the state, she said.

Exact Sciences has two labs in Madison and is planning on building a third site. It has 2,300 employees, including 1,800 in the Madison area.

Connelly said the out-of-state jobs noted in the audit were likely professional medical representatives or members of the company’s sales force.